Top Biotechnology & Medical Research stocks in Europe
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LONNLonza AG | CH₣36.26bn | 34.92 | 0.8% |
ARGXargenx SE | €20.05bn | n/a | n/a |
GMABGenmab A/S | DKK131.15bn | 30.38 | n/a |
BANBBACHEM HOLDING AG | CH₣5.90bn | 52.3 | 1.02% |
ZEALZealand Pharma A/S | DKK36.34bn | n/a | n/a |
MORMorphosys AG | €2.55bn | n/a | n/a |
EVTEvotec SE | €2.35bn | n/a | n/a |
BIONBB Biotech AG | CH₣2.27bn | n/a | 4.83% |
GLPGGalapagos NV | €1.79bn | 170.43 | n/a |
BIOA BBioArctic AB | SEK17.37bn | 75.95 | n/a |
GNSGenus | £1.13bn | 29.04 | 1.86% |
ALIF BAddLife AB | SEK11.97bn | 50.49 | 0.51% |
ABVXAbivax SA | €890.91m | n/a | n/a |
ERGOErgomed | £701.05m | 43.1 | n/a |
PHILPhilogen SpA | €735.29m | n/a | n/a |
FYBFormycon AG | €682.44m | 38.24 | n/a |
PRTCPuretech Health | £557.45m | n/a | n/a |
GUBRAGubra A/S | DKK4.61bn | n/a | n/a |
VLAValneva SE | €508.24m | n/a | n/a |
BSLNBasilea Pharmaceutica AG Allschwil | CH₣488.25m | 46.76 | n/a |